Demeter EVPrep
Commercial- Indications
- Research use only
Company intelligence / Profile preview
EXOKĒRYX has launched Demeter EVPrep™, an automated system for isolating extracellular vesicles with high purity and recovery, supporting downstream research. The company is developing additional products such as ExoScan for multiomic biomarker profiling. Their technology aims to enable earlier, more accurate disease detection through advanced sample preparation and analysis of exosomes from biological fluids. No clinical trial results are reported; the focus is on enabling research and diagnostics rather than direct therapeutic intervention at this stage[1][2].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EXOKĒRYX.